# Olema Pharmaceuticals, Inc.: Form 8-K, filed Oct 15, 2026

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: 8-K
- Filed: 2026-10-15
- Accepted by EDGAR: Oct 15, 2026, 17:00 ET
- Period: 2026-10-12
- Accession: 0001193125-26-423002
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000119312526423002/olma-20261012.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000119312526423002/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000119312526423002/olma-20261012.htm

Filed Oct 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-423002. Last ingested by Listed: Nov 10, 2026, 16:50 ET. No prices; not investment advice.